MTOR and lobular neoplasia: In conclusion, ORM1 could be a promising molecular marker for the diagnosis and treatment of LN as it can regulate the expression of autophagy components in podocytes through the AMPK/mTOR signaling pathway, thus influencing podocyte damage in the LN model in vitro.